Man Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.8M | Buy |
67,436
+61,185
| +979% | +$17.6M | 0.04% | 527 |
|
|
2025
Q4 | $1.89M | Sell |
6,251
-26,732
| -81% | -$8.34M | ﹤0.01% | 1465 |
|
|
2025
Q3 | $9.25M | Sell |
32,983
-47,305
| -59% | -$12.9M | 0.02% | 828 |
|
|
2025
Q2 | $19.4M | Buy |
80,288
+73,575
| +1,096% | +$17.4M | 0.04% | 520 |
|
|
2025
Q1 | $1.64M | Sell |
6,713
-1,005
| -13% | -$302K | ﹤0.01% | 1436 |
|
|
2024
Q4 | $2.54M | Buy |
+7,718
| New | +$2.62M | 0.01% | 1245 |
|
|
2024
Q1 | – | Sell |
-40,743
| Closed | -$13.2M | – | 2124 |
|
|
2023
Q4 | $13.2M | Buy |
+40,743
| New | +$12.8M | 0.04% | 534 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1216 |
|
|
2023
Q2 | – | Hold |
0
| – | -$7.61M | – | 1980 |
|
|
2023
Q1 | – | Sell |
-41,548
| Closed | -$19.4M | – | 644 |
|
|
2022
Q4 | $17.5M | Buy |
41,548
+29,914
| +257% | +$12.1M | 0.06% | 378 |
|
|
2022
Q3 | $4.85M | Buy |
+11,634
| New | +$5.8M | 0.02% | 745 |
|
|
2022
Q2 | – | Sell |
-44,697
| Closed | -$23.3M | – | 557 |
|
|
2022
Q1 | $25.2M | Buy |
44,697
+19,427
| +77% | +$11.7M | 0.09% | 257 |
|
|
2021
Q4 | $19.1M | Buy |
25,270
+15,973
| +172% | +$12M | 0.06% | 384 |
|
|
2021
Q3 | $6.93M | Buy |
9,297
+6,640
| +250% | +$4.97M | 0.02% | 714 |
|
|
2021
Q2 | $1.71M | Sell |
2,657
-1,209
| -31% | -$736K | 0.01% | 1265 |
|
|
2021
Q1 | $2.21M | Sell |
3,866
-3,039
| -44% | -$1.8M | 0.01% | 1071 |
|
|
2020
Q4 | $4.03M | Sell |
6,905
-6,542
| -49% | -$3.73M | 0.02% | 922 |
|
|
2020
Q3 | $6.93M | Buy |
13,447
+604
| +5% | +$306K | 0.03% | 647 |
|
|
2020
Q2 | $5.8M | Buy |
12,843
+4,075
| +46% | +$1.8M | 0.03% | 599 |
|
|
2020
Q1 | $3.07M | Sell |
8,768
-48,622
| -85% | -$17.9M | 0.02% | 697 |
|
|
2019
Q4 | $21.2M | Buy |
57,390
+39,522
| +221% | +$13.9M | 0.07% | 334 |
|
|
2019
Q3 | $5.95M | Buy |
17,868
+3,499
| +24% | +$1.14M | 0.02% | 796 |
|
|
2019
Q2 | $4.49M | Sell |
14,369
-12,553
| -47% | -$3.76M | 0.02% | 996 |
|
|
2019
Q1 | $8.23M | Buy |
26,922
+11,512
| +75% | +$3.11M | 0.03% | 673 |
|
|
2018
Q4 | $3.58M | Sell |
15,410
-30,081
| -66% | -$8.07M | 0.02% | 941 |
|
|
2018
Q3 | $14.2M | Buy |
45,491
+23,893
| +111% | +$7.42M | 0.05% | 455 |
|
|
2018
Q2 | $6.23M | Buy |
21,598
+14,254
| +194% | +$3.94M | 0.03% | 820 |
|
|
2018
Q1 | $1.84M | Buy |
+7,344
| New | +$1.87M | 0.01% | 1315 |
|
Other funds holding BIO
VCM
VPM
AI
